Target intelligence / Profile preview

XNDC1N-ZNF705EP-ALG1L9P readthrough (XNDC1N-ZNF705EP-ALG1L9P)

Target
XNDC1N-ZNF705EP-ALG1L9P
Molecular classification
Non-coding RNA, Readthrough transcript
01

Overview

The XNDC1N-ZNF705EP-ALG1L9P readthrough transcript arises from transcription spanning the XNDC1N, ZNF705EP, and ALG1L9P genes on chromosome 11q13.4. As a non-protein-coding RNA subject to nonsense-mediated decay, it is generally unlikely to have any direct biological or therapeutic role. The transcript does not encode a functional protein and is not recognized as a disease-associated gene or a druggable therapeutic target[1].\n\nThe main issue is that this entity is a non-coding, readthrough transcript, not a receptor, enzyme, transporter, or any typical drug target. It is generally not recognized in the literature as a relevant target for therapeutics, biomarker discovery, or mechanistic studies[1]. No interacting drugs, disease associations, or biological functions have been established.\n\nThe name itself is scientifically accurate for describing the transcript, but it is not a functional target in molecular medicine or pharmacology. This transcript is mainly notable in genomic annotation databases and has relevance only as a candidate for mRNA decay[1]. If you are seeking structured data for canonical targets (enzymes, receptors, transporters, etc.), this is not considered a valid therapeutic target, and thus most categories return null or not applicable.

Other names
XNDC1N-ZNF705EP-ALG1L9P readthroughXNDC1N-ZNF705EP-ALG1L9P
02

Mechanism of action

Not applicable; no known drugs target this molecule[1]

03

Biological functions

No confirmed biological function; candidate for nonsense-mediated decay[1]
04

Disease associations

None established; no data linking to disease or therapeutic roles[1]
05

Safety considerations

Not applicable; not a therapeutic target[1]
06

Interacting drugs

None reported, as it does not encode a protein and has no known drug interactions[1]
07

Biomarkers

None reported[1]

Beyond the preview

Go deeper on XNDC1N-ZNF705EP-ALG1L9P readthrough (XNDC1N-ZNF705EP-ALG1L9P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XNDC1N-ZNF705EP-ALG1L9P readthrough (XNDC1N-ZNF705EP-ALG1L9P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call